首页> Frontiers in pharmacology> Methylene blue in anticancer photodynamic therapy: systematic review of preclinical studies.

Methylene blue in anticancer photodynamic therapy: systematic review of preclinical studies.

导出 LinkOut

翻译打印收藏纠错

第一作者： Amir,Taldaev

第一单位： Laboratory of Nanobiotechnology, Institute of Biomedical Chemistry, Moscow, Russia.;Phystech School of Biological and Medical Physics, Moscow Institute of Physics and Technology (State University), Dolgoprudny, Russia.

作者： Amir,Taldaev ^[1] ; Roman,Terekhov ^[2] ; Ilya,Nikitin ^[2] ; Elizaveta,Melnik ^[2] ; Vera,Kuzina ^[2] ; Mikhail,Klochko ^[2] ; Igor,Reshetov ^[3] ; Artem,Shiryaev ^[3] ; Victor,Loschenov ^[4] ; Galina,Ramenskaya ^[2]

作者单位： Laboratory of Nanobiotechnology, Institute of Biomedical Chemistry, Moscow, Russia.;Phystech School of Biological and Medical Physics, Moscow Institute of Physics and Technology (State University), Dolgoprudny, Russia. ^[1] Nelyubin Institute of Pharmacy, I. M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia. ^[2] Department of Oncology, Radiotherapy and Reconstructive Surgery, University Clinical Hospital No. 1, Levshin Institute of Cluster Oncology, I. M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia. ^[3] Department of Laser Micro-Nano and Biotechnology, National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), Moscow, Russia. ^[4]

关键词 cancer methylene blue nanopharmaceutics photodynamic therapy systematic review tumor

DOI 10.3389/fphar.2023.1264961

PMID 37841915

发布时间 2023-10-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交